| Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.(Letters to the Editor): An article from: Southern Medical Journal | Digitalby Thein H. Oo (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 3 Pages | | Publication Date: | December 01, 2005 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Southern Medical Journal, published by Thomson Gale on December 1, 2005. The length of the article is 807 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Rituximab is effective in the treatment of refractory immune thrombocytopenic purpura associated with chronic lymphocytic leukemia.(Letters to the Editor)Author: Thein H. OoPublication: Southern Medical Journal (Magazine/Journal)Date: December 1, 2005Publisher: Thomson GaleVolume: 98 Issue: 12 Page: 1227(2)Distributed by Thomson Gale |
|
